Were you looking for information about Adcetris? Adcertis is a common misspelling of Adcetris.
If you have Hodgkin's lymphoma or a rare type of non-Hodgkin's lymphoma known as systemic anaplastic large cell lymphoma, your healthcare provider may prescribe Adcetris™ (brentuximab vedotin). This medication comes as an intravenous (IV) injection that is given by a healthcare provider once every three weeks. It is approved for use when other treatments have failed, and should only be given to adults.
Although some people may not have any problems with this medicine, most people who receive it will experience some type of side effect. Common reactions to this drug include diarrhea, nausea, and fatigue.
(For more information on this medicine, click Adcetris. This full-length article offers a complete overview of this drug, including how it works, safety warnings and precautions, and how the injection is administered. You can also click any of the links in the box to the right for specific information.)